FDA clears Teva's generic version of acne drug Solodyn

03/18/2009 | Globes (Israel) · Reuters

Teva Pharmaceutical Industries obtained FDA approval to market 45-mg, 90-mg and 135-mg doses of its copy of Solodyn, an acne medicine from Medicis Pharmaceutical. The decision was announced the same day that the companies ended their patent dispute over the launch of generic Solodyn.

View Full Article in:

Globes (Israel) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI